Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.51 |
| ▸ | NPC1 | O15118 | 7/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | APP | P05067 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GPR183 | P32249 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17976907 | 1.00 | RAB9A (0.51) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL17976885 | 0.90 | TRPV1 (0.58) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL16970309 | 0.90 | TRPV1 (0.58) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL17976912 | 0.88 | TRPV1 (0.52) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL15570578 | 0.88 | TRPV1 (0.52) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL17976876 | 0.87 | CCR2 (0.49) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL16970118 | 0.87 | CCR2 (0.49) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL15572463 | 0.85 | RAB9A (0.58) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL17976883 | 0.85 | RAB9A (0.58) | RAB9ANPC1SMN1; SMN2TRPV1HPGD | |
| SCHEMBL17976902 | 0.82 | RAB9A (0.52) | RAB9ANPC1SMN1; SMN2TRPV1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2888243-B1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LTD (IN) | 2016-08-17 | — | — | EP | claimed |
| US-9328092-B2 | Acrylamide compounds as histamine H3 receptor ligands | SUVEN LIFE SCIENCES LIMITED (IN) | 2016-05-03 | — | — | US | claimed |
| US-20150218129-A1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LIMITED (IN) | 2015-08-06 | — | — | US | claimed |
| EP-2888243-A1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | Suven Life Sciences Limited (IN) | 2015-07-01 | — | — | EP | claimed |
| WO-2014030170-A1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LIMITED (IN) | 2014-02-27 | — | — | WO | claimed |
| EP-2888243-B1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LTD (IN) | 2016-08-17 | — | — | EP | disclosed |
| US-9328092-B2 | Acrylamide compounds as histamine H3 receptor ligands | SUVEN LIFE SCIENCES LIMITED (IN) | 2016-05-03 | — | — | US | disclosed |
| US-20150218129-A1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LIMITED (IN) | 2015-08-06 | — | — | US | disclosed |
| EP-2888243-A1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | Suven Life Sciences Limited (IN) | 2015-07-01 | — | — | EP | disclosed |
| WO-2014030170-A1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | SUVEN LIFE SCIENCES LIMITED (IN) | 2014-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150218129-A1 | ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS | HRH3, HRH2, HRH4 | RAB9A 3826/4885NPC1 4438/4885SMN1; SMN2 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.